Arunjyothi Bio Ventures has successfully completed the acquisition and registration of a strategic property in Jangaon, Telangana. The company announced the finalization of the purchase, which includes 2 acres and 06 guntas of land along with a pre-constructed warehouse spanning 22,000 square feet.

Key Highlights

• Property Details: 2 acres 06 guntas of land with a 22,000 sq. ft. warehouse
• Location: Jangaon, Telangana

Acquisition Timeline

1. The Board of Directors approved the purchase from related parties.
2. Shareholders granted approval at an Extraordinary General Meeting.
3. Official registration of the land and warehouse in the company's name.

Corporate Governance

Arunjyothi Bio Ventures has adhered to proper corporate governance procedures throughout the acquisition process. The company followed the regulations set by the Securities and Exchange Board of India (SEBI) for related party transactions, ensuring transparency and shareholder approval.

Strategic Implications

The addition of land and a warehouse in Telangana could potentially enhance Arunjyothi Bio Ventures' operational capabilities in the region. The strategic location in Jangaon may provide logistical advantages for the company's bio ventures operations.

About Arunjyothi Bio Ventures

Arunjyothi Bio Ventures (CIN: L01400TG1986PLC062463) operates two plant units in Telangana and Andhra Pradesh. The company's registered office is located in Hyderabad, Telangana.

Investors and stakeholders can find more information about the company on its official website: www.abvl.co.in .

Arunjyothi Bio Ventures Limited, a company involved in retail chain stores, import-export, and trading in beverages and building materials, has reported a significant increase in profit for the first quarter, along with key leadership reappointments and a change in statutory auditors.

Financial Performance

The company's unaudited financial results for Q1 show a robust performance:

Despite a 13.73% decrease in net sales to ₹871.24 lakhs from ₹1,009.89 lakhs in the same quarter last year, Arunjyothi Bio Ventures managed to significantly boost its bottom line. The company's net profit surged by 39.69% to ₹236.39 lakhs, compared to ₹169.23 lakhs in the corresponding period of the previous year.

The improved profitability can be attributed to a substantial reduction in total expenses, which decreased by 17.52% year-over-year. This cost management strategy helped offset the impact of lower sales, resulting in a higher net profit margin.

Leadership Reappointments

The board of directors approved the reappointment of three whole-time directors for three-year terms, effective November 10, 2025:

1. Mr. Badari Narayana Murthy Pabbathi: With 23 years of experience in retail chain stores, import-export, trading, banking, and insurance.
2. Mr. Dathvik Pabbathi: Son of Mr. Badari Narayana Murthy Pabbathi, bringing six years of experience in the company's core business areas.
3. Mr. Nadimpalli Vishal: A postgraduate in business management with over 12 years of experience in distribution, manufacturing, wholesale trade, and e-commerce.

These reappointments are subject to shareholder approval and aim to ensure continuity in the company's leadership.

Auditor Transition

Arunjyothi Bio Ventures announced a change in its statutory auditors:

• M/s. V Ravi & Co., Chartered Accountants, resigned as the company's statutory auditors due to pre-occupation after completing one five-year term.
• M/s. PKF Sridhar & Santhanam LLP, a leading chartered accountancy firm with over 45 years of experience, has been appointed as the new statutory auditors for a five-year term, effective August 4, 2025, subject to shareholder approval.

Other Key Information

• The company's paid-up equity share capital stands at ₹1,863.81 lakhs.
• Arunjyothi Bio Ventures completed a stock split on January 17, 2025, changing the face value of shares from ₹10 to ₹1 per share.
• The total number of outstanding shares post-split is 18,63,81,000.

The company's ability to increase profitability despite lower sales demonstrates effective cost management and operational efficiency. The leadership renewals and auditor change indicate a focus on maintaining strong governance and financial oversight as Arunjyothi Bio Ventures moves forward in its growth trajectory.